miR-451a is a differentially expressed blood-based microRNA in newly diagnosed CML identified by high-throughput profiling
microRNAs (miRNAs) are emerging as promising biomarkers in hematological malignancies due to their stability in blood. This study aimed to investigate the differential expression of miRNAs in chronic myeloid leukemia (CML) and evaluate the potential of miR-451a as a candidate whole-blood miRNA marker. We c...